- Home
- CNM vs MEDP Comparison
CNM vs MEDP Comparison
Compare CNM & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNM
- MEDP
- Stock Information
- Founded
- CNM 1996
- MEDP 1992
- Country
- CNM United States
- MEDP United States
- Employees
- CNM N/A
- MEDP N/A
- Industry
- CNM Durable Goods
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- Sector
- CNM Consumer Discretionary
- MEDP Health Care
- Exchange
- CNM Nasdaq
- MEDP Nasdaq
- Market Cap
- CNM 9.9B
- MEDP 13.4B
- IPO Year
- CNM 2021
- MEDP 2016
- Fundamental
- Price
- CNM $50.90
- MEDP $585.82
- Analyst Decision
- CNM Buy
- MEDP Hold
- Analyst Count
- CNM 11
- MEDP 11
- Target Price
- CNM $60.64
- MEDP $451.70
- AVG Volume (30 Days)
- CNM 2.0M
- MEDP 347.3K
- Earning Date
- CNM 12-02-2025
- MEDP 10-22-2025
- Dividend Yield
- CNM N/A
- MEDP N/A
- EPS Growth
- CNM 7.24
- MEDP 25.36
- EPS
- CNM 2.25
- MEDP 14.32
- Revenue
- CNM $7,740,000,000.00
- MEDP $2,358,373,000.00
- Revenue This Year
- CNM $4.45
- MEDP $21.48
- Revenue Next Year
- CNM $4.43
- MEDP $11.90
- P/E Ratio
- CNM $22.65
- MEDP $41.35
- Revenue Growth
- CNM 11.02
- MEDP 13.88
- 52 Week Low
- CNM $41.64
- MEDP $250.05
- 52 Week High
- CNM $67.18
- MEDP $625.00
- Technical
- Relative Strength Index (RSI)
- CNM 40.41
- MEDP 62.02
- Support Level
- CNM $50.63
- MEDP $572.12
- Resistance Level
- CNM $52.52
- MEDP $602.54
- Average True Range (ATR)
- CNM 1.55
- MEDP 20.93
- MACD
- CNM -0.04
- MEDP -0.69
- Stochastic Oscillator
- CNM 17.04
- MEDP 59.40
About CNM Core & Main Inc.
Core & Main is a leading specialty distributor with a focus on water, wastewater, storm drainage, and fire protection products. The company provides solutions to municipalities, private water companies, and professional contractors across municipal, nonresidential, and residential end markets. The company's specialty products and services are used in the maintenance, repair, replacement, and construction of water and fire protection infrastructure.
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.